This study is the first to apply highly specific NT-proBNP thresholds for HF risk that adjust not only for age—as commonly done in research and clinical practice—but also for critical comorbidities such as obesity, impaired renal function, and AF. This evidence concerns the gene NPPB and obesity due to melanocortin 4 receptor deficiency.